Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Halldin

Showing results (111-120 of 235) with videos related to

Pageof 24
Sort By:
Archives of General Psychiatry|July 1, 1987
No D2 receptor increase in PET study of schizophreniaL Farde, F A Wiesel, H Hall, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDGP Bartenstein, S Asenbaum, A Catafau, et al.
AJNR. American Journal of Neuroradiology|July 1, 1985
Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomographyA Lilja, K Bergström, P Hartvig, et al.
Bioorganic & Medicinal Chemistry|April 20, 2001
Short and efficient syntheses of analogues of WAY-100635: new and potent 5-HT1A receptor antagonistsS Marchais, B Nowicki, H Wikström, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's diseaseG Sedvall, P Karlsson, A Lundin, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
11C-labelling of dimethylphenethylamine in two different positions and biodistribution studiesC Halldin, P Bjurling, C G Stålnacke, et al.
Psychiatry Research|April 1, 1993
PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controlsJ E Litton, J Neiman, S Pauli, et al.
British Journal of Pharmacology|March 3, 2004
Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effectsA K Larsen, L T Brennum, J Egebjerg, et al.
Neuroimage. Clinical|February 23, 2023
Longitudinal DAT changes measured with [<sup>18</sup>F]FE-PE2I PET in patients with Parkinson's disease; a validation studyV S Kerstens, P Fazio, M Sundgren, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
PET imaging of neuroreceptors in schizophreniaG Sedvall, S Pauli, P Karlsson, et al.
Pageof 24

Showing results (111-120 of 235) with videos related to

Sort By:
Pageof 24
Archives of General Psychiatry|July 1, 1987
No D2 receptor increase in PET study of schizophreniaL Farde, F A Wiesel, H Hall, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2002
European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDGP Bartenstein, S Asenbaum, A Catafau, et al.
AJNR. American Journal of Neuroradiology|July 1, 1985
Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomographyA Lilja, K Bergström, P Hartvig, et al.
Bioorganic & Medicinal Chemistry|April 20, 2001
Short and efficient syntheses of analogues of WAY-100635: new and potent 5-HT1A receptor antagonistsS Marchais, B Nowicki, H Wikström, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's diseaseG Sedvall, P Karlsson, A Lundin, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
11C-labelling of dimethylphenethylamine in two different positions and biodistribution studiesC Halldin, P Bjurling, C G Stålnacke, et al.
Psychiatry Research|April 1, 1993
PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controlsJ E Litton, J Neiman, S Pauli, et al.
British Journal of Pharmacology|March 3, 2004
Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effectsA K Larsen, L T Brennum, J Egebjerg, et al.
Neuroimage. Clinical|February 23, 2023
Longitudinal DAT changes measured with [<sup>18</sup>F]FE-PE2I PET in patients with Parkinson's disease; a validation studyV S Kerstens, P Fazio, M Sundgren, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
PET imaging of neuroreceptors in schizophreniaG Sedvall, S Pauli, P Karlsson, et al.
Pageof 24